isomethyleugenol has been researched along with ST Elevation Myocardial Infarction in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Akhmedov, A; Ambrosini, S; Beltrami, AP; Brown, PJ; Camici, GG; Costantino, S; Crea, F; Gorica, E; Hamdani, N; Herwig, M; Kiss, A; Kolijn, D; Liuzzo, G; Lüscher, TF; Matter, CM; Mohammed, SA; Montecucco, F; Paneni, F; Pedicino, D; Podesser, B; Rossi, FMV; Ruschitzka, F; Russo, G; Sciarretta, S; Szabó, PL; Vinci, R; Weber, L | 1 |
Shangguan, Q; Sheng, G; Xie, G; Yang, J; Yang, M | 1 |
2 other study(ies) available for isomethyleugenol and ST Elevation Myocardial Infarction
Article | Year |
---|---|
Methylation of the Hippo effector YAP by the methyltransferase SETD7 drives myocardial ischaemic injury: a translational study.
Topics: Animals; Antioxidants; Apoptosis; Histone-Lysine N-Methyltransferase; Humans; Leukocytes, Mononuclear; Methylation; Mice; Mice, Knockout; Myocytes, Cardiac; Rats; ST Elevation Myocardial Infarction | 2023 |
M6A regulator methylation patterns and characteristics of immunity in acute ST-segment elevation myocardial infarction.
Topics: Animals; Arrhythmias, Cardiac; Gene Regulatory Networks; Humans; Mammals; Methylation; Nomograms; ST Elevation Myocardial Infarction | 2023 |